GC
GNVC

Guggenheim Capital’s GenVec, Inc. GNVC Stock Holding History

Guggenheim Capital’s Portfolio GNVC Stock Details GNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,027
Closed -$26K – 3323
2014
Q2 		$26K Sell
1,027
-102
-9% -$2.5K ﹤0.01% 3146
2014
Q1 		$30K Buy
+1,129
New +$36.8K ﹤0.01% 3198

Other funds holding GNVC

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SIM
Spark Investment Management New York $51.2M AUM 87.14% 1-Year Est. Return

Guggenheim Capital's GNVC Position: Q3 2014 in Review

Guggenheim Capital sold out of GenVec, Inc. (GNVC) in Q3 2014, closing a stake of 1,027 shares — an estimated $26K sold.

Guggenheim Capital first reported a position in GNVC in Q1 2014 and held it in 2 quarters. The position peaked at $30K in Q1 2014. 21 funds tracked by Wall St. Rank hold GNVC as of Q3 2014.

  • Guggenheim Capital reported no remaining GenVec, Inc. position as of Q3 2014 after selling out during the quarter.
  • Guggenheim Capital sold 1,027 GenVec, Inc. shares in Q3 2014, an estimated $26K.
  • Guggenheim Capital first reported a position in GenVec, Inc. in Q1 2014 and held it in 2 quarters.
  • Guggenheim Capital's GenVec, Inc. position peaked at $30K in Q1 2014.
  • 21 funds tracked by Wall St. Rank held GenVec, Inc. as of Q3 2014.

Based on Guggenheim Capital's 13F filing for Q3 2014, filed 14 Nov 2014.